Dupracetam

Nootropic

Dupracetam is retained as a catalog identity with independently verified primary-literature context. No qualified exposure model, dose recommendation, efficacy claim, or safety claim is provided.

Pharmacokinetic model

A route-level PK model for dupracetam is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.

Key facts

Category
Nootropic
Suggested cadence
once daily

Research behind this entry

  1. [1-Methylhydantoin, an unexpected metabolite of the intelligence-affecting substance dupracetam (author's transl)]. Dell HD, Jacobi H, Kamp R, Kurz J, Wünsche C · Archiv der Pharmazie, 1981 DOI

    This citation reports a primary research study involving Dupracetam. It does not establish a qualified human dose, safety profile, efficacy claim, or pharmacokinetic route for this catalog record.

1 published study referenced in the app, each with a plain-language summary.